<p>Cumulative incidence of mortality up to four years after start of ART by region, corrected in South Africa for mortality under-ascertainment.</p
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Kaplan-Meier estimates of cumulative annualised mortality rates between men and women accessing A...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...
<p>Cumulative incidence of mortality up to four years after start of ART by region and CD4 count at ...
<p>*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...
<p>Mortality rates following ART initiation stratified by age at initiation and cohort period time (...
<p>Regional disease specific incidence of WHO stage 4 conditions in months 0–3 following ART initiat...
<p>Cumulative Incidence of Mortality and Loss to Follow-up (LTFU) among Adults Enrolled in Côte d'Iv...
<p>Disease specific Incidence of WHO stage 4 conditions in months 0–3 following ART initiation by ag...
Mortality rates per 100 person-years over the study period in different ART centers (N = 3,363).</p
<p>Regional disease specific incidence of WHO stage 3 conditions in months 0–3 following ART initiat...
<p>Patients were counted as LTF starting at 90 days after the enrollment visit, as a result the cumu...
<p>Disease specific Incidence of WHO stage 3 conditions in months 0–3 following ART initiation by ag...
Multivariable predictors of 1-year mortality after ART initiation in the derivation cohort (N = 7,03...
<p>Annual probability of dying by (a) all-causes and (b) specific causes, Agincourt, South Africa, 1...
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Kaplan-Meier estimates of cumulative annualised mortality rates between men and women accessing A...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...
<p>Cumulative incidence of mortality up to four years after start of ART by region and CD4 count at ...
<p>*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...
<p>Mortality rates following ART initiation stratified by age at initiation and cohort period time (...
<p>Regional disease specific incidence of WHO stage 4 conditions in months 0–3 following ART initiat...
<p>Cumulative Incidence of Mortality and Loss to Follow-up (LTFU) among Adults Enrolled in Côte d'Iv...
<p>Disease specific Incidence of WHO stage 4 conditions in months 0–3 following ART initiation by ag...
Mortality rates per 100 person-years over the study period in different ART centers (N = 3,363).</p
<p>Regional disease specific incidence of WHO stage 3 conditions in months 0–3 following ART initiat...
<p>Patients were counted as LTF starting at 90 days after the enrollment visit, as a result the cumu...
<p>Disease specific Incidence of WHO stage 3 conditions in months 0–3 following ART initiation by ag...
Multivariable predictors of 1-year mortality after ART initiation in the derivation cohort (N = 7,03...
<p>Annual probability of dying by (a) all-causes and (b) specific causes, Agincourt, South Africa, 1...
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Kaplan-Meier estimates of cumulative annualised mortality rates between men and women accessing A...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...